Evaxion A (EVAX) Total Liabilities (2019 - 2026)
Evaxion A posted quarterly Total Liabilities of $10.4 million for Q1 2026, down 29.95% year-on-year from $14.9 million in Q1 2025, and down 8.22% on a QoQ basis from $11.4 million in Q4 2025.
Evaxion A (EVAX) has 8 years of Total Liabilities data on file, last reported at $10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 29.95% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 29.95% YoY), and the FY2025 full-year result was $11.4 million, down 19.58% from the prior year.
- Total Liabilities for Q1 2026 stood at $10.4 million, down from $11.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $16.2 million in Q2 2025 and bottomed at $20050.0 in Q1 2024.
- The 5-year median for Total Liabilities is $13.9 million (2022), against an average of $11.3 million.
- The widest annual swing landed in 2024, when Total Liabilities tumbled 99.86%; it then jumped 74194.26% in 2025.
- A 5-year view of Total Liabilities shows it stood at $573000.0 in 2022, then tumbled by 66.84% to $190000.0 in 2023, then soared by 7340.53% to $14.1 million in 2024, then decreased by 19.58% to $11.4 million in 2025, then declined by 8.22% to $10.4 million in 2026.
- The last three Total Liabilities figures came in at $10.4 million (Q1 2026), $11.4 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 753.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Jun 30, 2024 | 13.98 Mn |
| Mar 31, 2024 | 20,050.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 14.68 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 573,000.00 |
| Sep 30, 2022 | 13.90 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 5.83 Mn |
| Mar 31, 2021 | 7.12 Mn |
| Dec 31, 2020 | 4.93 Mn |
| Dec 31, 2019 | 1.72 Mn |